指南与共识心血管CT

冠状动脉CT血管造影人工智能评估用于动脉粥样硬化个体化药物治疗:QCI研究组共识声明

Coronary CT angiography evaluation with artificial intelligence for individualized medical treatment of atherosclerosis: a Consensus Statement from the QCI Study Group.
指南 / 共识 · Nat Rev Cardiol · 2025-08-01

该共识声明由定量心血管影像(QCI)研究组基于2024年9月第三届国际会议后的三步Delphi流程制定,专家同意使用基于DISCHARGE和SCOT-HEART试验斑块数据的年龄和性别校正百分位曲线。QCI研究组推荐:存在任何动脉粥样硬化斑块即应推荐药物治疗,总斑块体积达第70百分位需高强度治疗。

要点

  • QCI研究组推荐:存在任何动脉粥样硬化斑块即应推荐药物治疗。
  • 总斑块体积达第70百分位需高强度治疗,采用年龄和性别校正百分位曲线。
  • 专家同意使用基于DISCHARGE和SCOT-HEART试验斑块数据的百分位曲线。

核心结论

  • QCI研究组推荐存在任何动脉粥样硬化斑块即应推荐药物治疗,总斑块体积达第70百分位需高强度治疗,旨在为未来试验奠定基础并释放冠状动脉CT血管造影改善患者结局的潜力。

研究设计与样本

  • 该共识声明由定量心血管影像(QCI)研究组制定,基于2024年9月第三届国际QCI研究组会议后的三步Delphi流程,专家来自心血管影像多个领域。
  • 专家同意使用基于DISCHARGE和SCOT-HEART试验冠状动脉斑块数据的年龄和性别校正百分位曲线。

诊断标准与关键数值

  • 推荐使用基于DISCHARGE和SCOT-HEART试验斑块数据的年龄和性别校正百分位曲线。
  • 存在任何动脉粥样硬化斑块即应推荐药物治疗。
  • 总斑块体积达第70百分位需高强度治疗。

临床应用与阅片要点

  • QCI研究组推荐存在任何动脉粥样硬化斑块即应推荐药物治疗。
  • QCI研究组推荐总斑块体积达第70百分位需高强度治疗,采用年龄和性别校正百分位曲线。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Coronary CT angiography is widely implemented, with an estimated 2.2 million procedures in patients with stable chest pain every year in Europe alone. In parallel, artificial intelligence and machine learning are poised to transform coronary atherosclerotic plaque evaluation by improving reliability and speed. However, little is known about how to use coronary atherosclerosis imaging biomarkers to individualize recommendations for medical treatment. This Consensus Statement from the Quantitative Cardiovascular Imaging (QCI) Study Group outlines key recommendations derived from a three-step Delphi process that took place after the third international QCI Study Group meeting in September 2024. Experts from various fields of cardiovascular imaging agreed on the use of age-adjusted and gender-adjusted percentile curves, based on coronary plaque data from the DISCHARGE and SCOT-HEART trials. Two key issues were addressed: the need to harness the reliability and precision of artificial intelligence and machine learning tools and to tailor treatment on the basis of individualized plaque analysis. The QCI Study Group recommends that the presence of any atherosclerotic plaque should lead to a recommendation of pharmacological treatment, whereas the 70th percentile of total plaque volume warrants high-intensity treatment. The aim of these recommendations is to lay the groundwork for future trials and to unlock the potential of coronary CT angiography to improve patient outcomes globally.

来源:Nat Rev Cardiol,查看原文。版权归原作者所有。

引用

  1. Schulze K, Stantien AM, Williams MC, et al. Coronary CT angiography evaluation with artificial intelligence for individualized medical treatment of atherosclerosis: a Consensus Statement from the QCI Study Group. Nat Rev Cardiol. 2025. PMID: 40751112. doi:10.1038/s41569-025-01191-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。